Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma

Published:2018-09 Issue:3 Volume:200 Page:528-534
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bhindi Bimal¹,Habermann Elizabeth B.²,Mason Ross J.¹,Costello Brian A.³,Pagliaro Lance C.³,Thompson R. Houston¹,Leibovich Bradley C.¹,Boorjian Stephen A.¹

Affiliation:

1. Department of Urology, Mayo Clinic, Rochester, Minnesota

2. Department of Health Services Research, Mayo Clinic, Rochester, Minnesota

3. Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology;Motzer;J Natl Compr Canc Netw,2017

2. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis;Flanigan;J Urol,2004

3. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

4. Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a National Cancer Data Base study;Hanna;J Clin Oncol,2016

5. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium;Heng;Eur Urol,2014

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive nephrectomy in metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2024-06-07

2. Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study;Diseases;2024-06-04

3. Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients;Urology;2023-12

4. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium;European Urology Oncology;2023-10

5. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC;Nature Reviews Urology;2023-07-03